Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2009

01-09-2009 | Original Article

Helicobacter pylori Infection as a Risk Factor for Insulin Resistance

Authors: Ahad Eshraghian, Seyed Ali Hashemi, Alireza Hamidian Jahromi, Hamed Eshraghian, Seyed Masoum Masoompour, Mohamad Ali Davarpanah, Kavus Eshraghian, Seyed Alireza Taghavi

Published in: Digestive Diseases and Sciences | Issue 9/2009

Login to get access

Abstract

This study aimed to determine the relation between Helicobacter pylori infection and insulin resistance in healthy subjects. In a cross-sectional case control study between January and April 2007, a total of 71 healthy subjects without the exclusion criteria completed the study. Forty-three (60.6%) patients were H. pylori positive and 28 (39.4%) patients were H. pylori negative. Age and body mass index of the patients were not significantly different between the two groups (32.2 ± 14.2 vs. 33 ± 8.05 years and 23.15 ± 4.5 vs. 24.04 ± 3.2 kg/m2, respectively). H-pylori-positive patients had significantly higher HOMA-IR level compared to H-pylori-negative patients (3.54 ± 2.2 vs. 2.46 ± 1.9, respectively) (< 0.05). Fasting serum insulin level was significantly higher in the H-pylori-positive group compared with the H-pylori-negative group (19.41 ± 3.08 vs. 16.57 ± 2.02 μU/ml, respectively) (< 0.05). Our findings suggest recognition of H. pylori infection as a risk factor for insulin resistance.
Literature
4.
go back to reference Misiewicz JJ. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995;7:701–703.PubMed Misiewicz JJ. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995;7:701–703.PubMed
5.
go back to reference Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol. 2003;29:351–359.PubMed Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol. 2003;29:351–359.PubMed
7.
go back to reference Moller DE, Flier J. Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325:938–948.PubMed Moller DE, Flier J. Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325:938–948.PubMed
10.
go back to reference Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996–1001.PubMed Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996–1001.PubMed
15.
go back to reference Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. doi:10.2337/diacare.23.1.57.PubMedCrossRef Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. doi:10.​2337/​diacare.​23.​1.​57.PubMedCrossRef
23.
go back to reference Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29:1058–1064. doi:10.2337/dc05-2068.PubMedCrossRef Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29:1058–1064. doi:10.​2337/​dc05-2068.PubMedCrossRef
26.
go back to reference Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest. 1984;74:417–423. doi:10.1172/JCI111437.PubMedCrossRef Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest. 1984;74:417–423. doi:10.​1172/​JCI111437.PubMedCrossRef
27.
31.
go back to reference Salles N, Ménard A, Georges A, et al. Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. J Gerontol A Biol Sci Med Sci. 2006;61:1144–1150.PubMed Salles N, Ménard A, Georges A, et al. Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. J Gerontol A Biol Sci Med Sci. 2006;61:1144–1150.PubMed
33.
go back to reference Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol. 2005;7:695–699. Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol. 2005;7:695–699.
34.
go back to reference Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMed Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMed
35.
go back to reference Park SH, Jeon WK, Kim SH, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97:508–513.PubMed Park SH, Jeon WK, Kim SH, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97:508–513.PubMed
36.
go back to reference Ozdem S, Akcam M, Yilmaz A, Artan R. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest. 2007;30:36–40. Ozdem S, Akcam M, Yilmaz A, Artan R. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest. 2007;30:36–40.
37.
go back to reference Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229–238. doi:10.1016/j.ijcard.2006.12.003.PubMedCrossRef Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229–238. doi:10.​1016/​j.​ijcard.​2006.​12.​003.PubMedCrossRef
Metadata
Title
Helicobacter pylori Infection as a Risk Factor for Insulin Resistance
Authors
Ahad Eshraghian
Seyed Ali Hashemi
Alireza Hamidian Jahromi
Hamed Eshraghian
Seyed Masoum Masoompour
Mohamad Ali Davarpanah
Kavus Eshraghian
Seyed Alireza Taghavi
Publication date
01-09-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0557-7

Other articles of this Issue 9/2009

Digestive Diseases and Sciences 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.